BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, May 15, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 9, 2008
View Archived Issues
D-Cycloserine does not affect social withdrawal in autistic children
Read More
Recent patents impart new therapeutic agents for cancer
Read More
FDA approves Hawaii Biotech's West Nile vaccine study in healthy volunteers
Read More
Dosing begins in Japanese AEGIS registration study of Soliris for PNH
Read More
BioSante begins phase III study of LibiGel for female hypoactive sexual desire disorder
Read More
Allos initiates phase IIb study of PDX in patients with non-small cell lung cancer
Read More
Phase II clinical study of MORAb-009 for pancreatic cancer begins
Read More
Exelixis initiates phase I/II trial of XL-184 for non-small cell lung cancer
Read More
Melanin-concentrating hormone, a potential antidepressant target
Read More
New ferritin light chain gene mutant mice, useful to study neuroferritinopathy / News in Context
Read More
Phase II clinical trial of Plicera for Gaucher disease gives positive results
Read More
Positive results from phase IIa clinical trial of MAXY-G34 for neutropenia
Read More
Orexigen reports positive 48-week results from phase IIb clinical trial of Empatic for obesity
Read More
Coronado initiates phase I trial of fourth-generation doxorubicin analogue
Read More
E.U. orphan drug status granted for RdCVF for retinitis pigmentosa
Read More
Ardea's lead NNRTI for HIV to enter phase IIa proof-of-concept trial
Read More
FDA approves Cialis for once daily use in treating erectile dysfunction
Read More
Novel agents for respiratory and allergic disorders claimed in recent patents
Read More
Two Movetis compounds successfully progressing through phase II clinical trials
Read More
Novel diagnostic agents disclosed by GE Healthcare
Read More
Ocera Therapeutics receives orphan drug status for AST-120 in pouchitis
Read More
Phase I trial commences for oxazolidinone antibacterial drug, TR-701
Read More